WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2001030345) CLONIDINE PREPARATIONS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2001/030345    International Application No.:    PCT/US2000/028776
Publication Date: 03.05.2001 International Filing Date: 18.10.2000
Chapter 2 Demand Filed:    25.05.2001    
IPC:
A61K 31/165 (2006.01), A61K 31/415 (2006.01), A61K 31/4168 (2006.01), A61K 47/32 (2006.01)
Applicants: CURATEK PHARMACEUTICALS HOLDING, INC. [US/US]; Suite 350N, 3773 Howard Hughes Parkway, Las Vegas, NV 89109 (US)
Inventors: BORGMAN, Robert, J.; (US)
Agent: CEPURITIS, Talivaldis; Olson & Hierl, Ltd., 36th Floor, 20 North Wacker Drive, Chicago, IL 60606 (US)
Priority Data:
09/427,367 26.10.1999 US
Title (EN) CLONIDINE PREPARATIONS
(FR) PREPARATIONS DE CLONIDINE
Abstract: front page image
(EN)Sympathetically maintained peripheral neuropathic pain syndromes are relieved by topically applying, to the affected region of a patient suffering from such pain, a pain relieving amount of an aqueous gel comprising clonidine, a water-gelling amount of a pharmaceutically acceptable gelling agent and having a physiologically tolerable pH value. Pain relief was achieved with applied amounts of clonidine in the range of about 2 milligrams per day to about 6 milligrams per day.
(FR)L'invention concerne des syndromes de douleurs neuropathiques périphériques entretenus par le système sympathique, soulagés par application locale, sur la région concernée du patient souffrant de telles douleurs, d'une dose analgésique d'un gel aqueux contenant de la clonidine, une dose gélifiante aqueuse d'un agent gélifiant pharmaceutiquement acceptable et présentant un pH physiologiquement acceptable. On soulage la douleur par application d'une dose de clonidine comprise entre environ 2 milligrammes et environ 6 milligrammes par jour.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)